|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$600
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$1,187
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$1,995
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$37,927
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$591,339
|
$236,536
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$67,654
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
$1,250
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
$600
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-04
|
$257,562
|
$257,562
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-03
|
$161,692
|
$80,846
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
$7,494
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
$3,699
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
$1,384
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
$1,800
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S5
|
$113,563
|
$3,407
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S6
|
$75,709
|
$2,271
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S7
|
$75,000
|
$2,250
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S8
|
$166,146
|
$4,984
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
$68,549
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
5R01CA095684-14
|
$275,378
|
$275,378
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
5R01CA172447-05
|
$305,025
|
$305,025
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-45
|
$5,113,872
|
$204,555
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
|
5R01CA165469-05
|
$381,420
|
$381,420
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
|
5R01CA173085-05
|
$328,888
|
$328,888
|
BRAUN, BENJAMIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
5R01CA167169-05
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-05
|
$318,513
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
The role of Sin3B in normal and malignant hematopoietic stem cell functions
|
5F30CA203047-02
|
$49,044
|
$49,044
|
CANTOR, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
5UH2CA213385-02
|
$49,295
|
$49,295
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
1K08CA194275-01A1
|
$177,336
|
$177,336
|
CHUNG, STEPHEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-14S1
|
$24,361
|
$24,361
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-14
|
$307,800
|
$307,800
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
2R01CA101774-15
|
$336,656
|
$336,656
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-10S1
|
$124,964
|
$4,999
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-10S2
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-10
|
$2,266,216
|
$90,649
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
OHSU Knight Cancer Institute
|
2P30CA069533-19
|
$2,310,000
|
$115,500
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Characterizing the landscape of resistance and persistence mechanisms in CML
|
2R01CA065823-21A1
|
$329,175
|
$329,175
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-19S1
|
$124,990
|
$6,250
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-19S2
|
$174,792
|
$8,740
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-16S1
|
$122,824
|
$4,913
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-16S2
|
$243,947
|
$9,758
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
$172,228
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
$262,200
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
5R01CA174205-05
|
$320,588
|
$320,588
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S1
|
$60,000
|
$2,400
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S2
|
$125,000
|
$5,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $16,629,705
|